SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Swet-Chem Antibiotics Ltd (531186)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531186 NSE: Pharmaceuticals & Drugs | Small Cap | Swet-Chem Antibiotics Share Price

BSE Share Price
Not Listed

Swet-Chem Antibiotics Ltd (531186)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531186 NSE: Pharmaceuticals & Drugs | Small Cap | Swet-Chem Antibiotics Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹0 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹-0
TTM Sales
₹0 Cr.
Book Value per Share
₹10
P/E Ratio
0.00
Industry PE
46.6
Price to Book (P/B)
0.00
Price to Sales (P/S)
0.00
EV/EBITDA
0.00
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
-0.46%
Return on Capital Employed (ROCE)
-0.39%
Return on Assets (ROA)
-0.26%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
-
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-100.55%
Asset Quality
Promoter Holding
0.00%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹0 Cr.
Face Value
₹10
All Time Low / High
₹1.50 / 7.00

Swet-Chem Antibiotics stock performance

Key Ratios
mw4me loader

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14TTM
ROCE % 0%0%0%0%0%0%0%0%101.4%-0.4%-

Growth Parameters

Sales 00000009.7000
Sales YoY Gr.-NANANANANANANA-100%NA-
Adj EPS 000000-0.54.12.8-0-0
YoY Gr.-NANANANANANANA-32.4%-100.7%-
BVPS (₹) 000000004.64.610
Adj Net
Profit
000000-0.42.71.8-0-0
Cash Flow from Ops. 000000004.3-0-
Debt/CF from Ops. 000000000.1-142.2-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NANANANA
Adj EPS NANANA-100.7%
BVPSNANANA-0.4%
Share Price - - - -

Key Financial Parameters

Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14TTM
Return on
Equity %
00000000119.7-0.5-0.3
Op. Profit
Mgn %
000000031.300NAN
Net Profit
Mgn %
000000027.800NAN
Debt to
Equity
000000000.20.2-
Working Cap
Days
000000061000
Cash Conv.
Cycle
0000000178000

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'11Mar'12Mar'13Mar'14
Sales09.6800
Operating Expenses + 06.650.010.01
Manufacturing Costs0000
Material Costs06.6400
Employee Cost 0000
Other Costs 00.020.010.01
Operating Profit -03.03-0.01-0.01
Operating Profit Margin (%) -31.3%--
Other Income + 00.011.860
Exceptional Items 0000
Interest 000.030
Depreciation 0.340.3400
Profit Before Tax -0.352.691.82-0.01
Tax 0000
Profit After Tax -0.352.691.82-0.01
PAT Margin (%) -27.8%--
Adjusted EPS (₹)0.00.02.8-0.0
Dividend Payout Ratio (%)0%0%0%0%

Valuation of Swet-Chem Antibiotics - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'11Mar'12Mar'13Mar'14

Equity and Liabilities

Shareholders Fund + -3.95-1.263.043.03
Share Capital 6.606.606.606.60
Reserves -10.55-7.86-3.56-3.57
Debt +000.600.54
Long Term Debt000.600.54
Short Term Debt0000
Minority Interest0000
Trade Payables001.661.66
Others Liabilities 3.951.260.070.08
Total Liabilities 005.385.31

Fixed Assets

Net Fixed Assets +3.202.861.511.51
Gross Block3.202.865.535.53
Accumulated Depreciation004.034.03
CWIP 000.420.42
Investments 0000
Inventories6.64000
Trade Receivables1.401.401.401.40
Cash Equivalents 000.010.01
Others Assets -11.24-4.262.041.98
Total Assets 005.385.31

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'13Mar'14
Cash Flow From Operating Activity + 4.29-0
PBT 1.82-0.01
Adjustment 2.480
Changes in Working Capital -0.010.01
Tax Paid 00
Cash Flow From Investing Activity + 1.350
Capex 00
Net Investments 00
Others 1.350
Cash Flow From Financing Activity + -5.640
Net Proceeds from Shares 00
Net Proceeds from Borrowing 00
Interest Paid 00
Dividend Paid 00
Others -5.640
Net Cash Flow 0.01-0

Financial Ratio

PARTICULARSMar'11Mar'12Mar'13Mar'14
Ratios
ROE (%)N/AN/A204.19-0.46
ROCE (%)N/AN/A101.43-0.39
Asset Turnover Ratio0000
PAT to CFO Conversion(x)N/A-00N/A
Working Capital Days
Receivable Days052.8000
Inventory Days0000
Payable Days0000

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Swet-Chem Antibiotics Ltd FAQs

The current trading price of Swet-Chem Antibiotics on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Swet-Chem Antibiotics stood at ₹0.00 Cr

The latest P/E ratio of Swet-Chem Antibiotics as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Swet-Chem Antibiotics as of 31-Dec-1969 is 0.00.

The 52-week high of Swet-Chem Antibiotics is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Swet-Chem Antibiotics is ₹0.00 ( Cr.) .

Data is not available for this company.

No data found

No data found

About Swet-Chem Antibiotics Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×